September 2017 in “Journal of Investigative Dermatology” The new scalp treatment preserves hair color, reduces hair loss, and maintains hair strength.
June 2017 in “Journal of evolution of medical and dental sciences” About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.
October 2011 in “InTech eBooks” Menstrual cycles can be irregular for women of childbearing age.
July 2002 in “Journal of applied cosmetology” Hair growth issues can be linked to genetics, diseases, or medications, and new treatments are being developed.
December 2025 in “Applied and Computational Engineering” Hair dyes can be harmful, but risks vary by person and can be reduced.
December 2025 in “Cosmetics” New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.
Machine learning can accurately predict Polycystic Ovary Syndrome in women using clinical features.
Topical minoxidil increases hair density in androgenetic alopecia but has unclear clinical significance.
April 2025 in “Pharmacy Practice” Long-term use of hormonal contraceptives may harm liver function.
February 2025 in “Prospects in Pharmaceutical Sciences” Clascoterone is a promising topical treatment for hair loss and acne with fewer side effects.
January 2025 in “International Journal of Advanced Biochemistry Research” Microsporum spp. is the most common fungus causing skin infections in dogs.
December 2024 in “PubMed” Freezia cream helps regrow hair in people with Alopecia Areata.
April 2024 in “Clinical and experimental dermatology” Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.
October 2023 in “Materials chemistry and physics (Print)” Adding keratin to a mix of cow hair and plant-based plastic makes it stronger.
Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.
November 2019 in “Aktualʹnì pitannâ farmacevtičnoï ì medičnoï nauki ta praktiki” Minoxidil-based alopecia treatments are common in Ukraine, but there's a shortage of combined medicines and few domestic options.
April 2018 in “Journal of Investigative Dermatology” The research found that a specific skin cell type not only triggers hair growth but also controls hair color, and that aging can lead to hair loss and color changes.
Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.
January 1988 in “Inpharma (Balgowlah)” New retinoids are effective for various skin conditions and are being developed to have fewer side effects.
Androgenetic alopecia may be linked to severe COVID-19.
April 2012 in “The Journal of Urology” Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.
119 citations
,
August 2010 in “Journal of Investigative Dermatology” Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.
86 citations
,
November 2020 in “Annals of Oncology” Early intervention and tailored management can reduce skin side effects from cancer treatments.
61 citations
,
January 1970 in “Toxicology and Applied Pharmacology”
59 citations
,
September 2008 in “Mycoses” Seborrheic dermatitis lowers quality of life more for women, younger people, and those with more education.
57 citations
,
August 2020 in “Journal of the American Geriatrics Society” Most adults over 70 have skin diseases needing treatment, with men more affected than women.
52 citations
,
October 2010 in “Antiviral Therapy” New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.
39 citations
,
March 2009 in “Archives of Dermatological Research” Apigenin may help promote hair growth and could treat hair loss.
37 citations
,
January 2022 in “Frontiers in Genetics” Aging reduces dermal sheath cells, affecting youthful skin appearance.
36 citations
,
July 1980 in “Journal of Toxicology and Environmental Health” High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.